Skip to main content
SpringerLink
Log in

Angiogenesis and the unique nature of tumor matrix

  • Review
  • Published:
Molecular Biotechnology Aims and scope Submit manuscript

Abstract

In this article we consider the factors responsible for the unique nature of the pericellular matrix of solid tumors and we discuss the role of alterations of tumor blood vessel structure. We examine the role of VEGF (vascular endothelial growth factor), a factor controlling permeability of capillaries, plasma protein extravasation, and the formation of a fibrin barrier. We discuss how this barrier could be destroyed by metalloproteinases bound on the surface of endothelial cells migrating through the matrix and how these enzymes are responsible for the activation of gelatinases that destroy basement membranes. The process called tubulogenesis, which gives rise to hyperpermeable tumor capillaries, will also be described. Alterations of the blood vessel structure leading to hypoxia of the matrix, and accumulation of plasma proteins and of blood cells will be treated. Finally, we review some of the strategies that might exploit this knowledge about the nature of the tumoral matrix for designing novel anticancer treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brown, J.M. and Giaccia, A.J. (1998) The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res. 58, 1408–1416.

    PubMed  CAS  Google Scholar 

  2. Grunt, T.W., Lametschwandtner, A., and Staindl, O. (1995) The vascular pattern of basal cell tumors: light microscopy and scanning electron microscopy study on vascular corrosion casts. Microvasc. Res. 29, 371–386.

    Article  Google Scholar 

  3. Dewhirst, M.W., Tso, C.Y., Oliver, R., Gustafson, C.S., Socomb, T.W., and Gross, J.F. (1989) Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature. Int.J.Radiat.Oncol.Biol.Phys. 17, 91–99.

    PubMed  CAS  Google Scholar 

  4. Gullino, P.M. (1996) The internal milieu of tumors. Prog. Exp. Tumor Res. 8, 1–25.

    Google Scholar 

  5. Gullino, P.M., Ziche, M., and Alessandri, G. (1990) Gangliosides, copper ions and angiogenic capacity of adult tissues. Cancer Metastasis Rev. 9, 239–251.

    Article  PubMed  CAS  Google Scholar 

  6. Alessandri, G., Cornaglia-Ferraris, P., and Gullino, P.M. (1997) Angiogenic and angiostatic microenvironment in tumors. Role of gangliosides. Acta Oncol. 36, 383–387.

    PubMed  CAS  Google Scholar 

  7. Srinivas, V., Zhu, X., Salceda, S., Nakamura, R., and Caro, J. (1998) Hypoxia -inducible factor (HIF-1alpha) is a non-heme iron protein. Implications for oxigen sensing. J. Biol. Chem. 273, 18019–18022.

    Article  PubMed  CAS  Google Scholar 

  8. Chiarugi, V., Magnelli, L., Chiarugi, A., and Gallo, O. (1999) Hypoxia induces pivotal tumor angiogenesis control factors including p53, vascular endothelial growth factor, and the NFkappaB-dependent inducible nitric oxide synthase and cyclooxygenase-2. J. Cancer Res. Clin. Oncol. 125, 525–528.

    Article  PubMed  CAS  Google Scholar 

  9. Blancher, C. and Harris A.L. (1998) The molecular basis of the hypoxia response patway: tumor hypoxia as a therapy target. Cancer Metastasis Rev. 17, 187–194.

    Article  PubMed  CAS  Google Scholar 

  10. Guillemin, K. and Krasnow, M.A. (1997) The hypoxic response: huffing and HIFing. Cell 89, 9–12.

    Article  PubMed  CAS  Google Scholar 

  11. Tsuji, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M. and Dubois, R.N. (1998) Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93, 705–716.

    Article  PubMed  Google Scholar 

  12. Korpelainen, E.I., and Alitalo, K. (1998) Signaling angiogenesis and lymphangiogenesis. Curr. Opin. Cell.Biol. 10, 159–164.

    Article  PubMed  CAS  Google Scholar 

  13. Hiraoka, N., Allen, E., Apel, I.J., Gyetko, M.R., and Weiss, S.J. (1998) Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95, 365–377.

    Article  PubMed  CAS  Google Scholar 

  14. Zucker, S., Mirza, H., Conner, C., Lorenz, A.F., Drews, M.H., Bahou, W.F. and Jesty, J. (1998) Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Int. J. Cancer 75, 780–786.

    Article  PubMed  CAS  Google Scholar 

  15. Bellamy, W.T., Richter, L., Frutiger, Y., and Gronan, T.M. (1999) Expression of vascular endothelial growth factor and its receptors in hematopoietic malignacies. Cancer Res. 59, 728–733.

    PubMed  CAS  Google Scholar 

  16. Forsyth, P.A., Wong, H., Laing, T.D., et al. (1999) Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of pathophysiology of malignant gliomas. Br. J. Cancer 79, 1828–1835.

    Article  PubMed  CAS  Google Scholar 

  17. Yabkowitz, R., Meyer, S., Black, T., Elliot, G., Merewhether, L.A. and Yamane, H.K. (1999) Inflammatory cytokines and vascular endothelial growth factor stimulate the release of soluble tie receptor from human endothelial cells via metalloproteinase activation. Blood 15, 1969–1979.

    Google Scholar 

  18. Forsyth, P.A., Laing, T.D., Gibson, A.W., Rewcastle, N.B., Brasher, P., Sutherland, G., Johnston, R.N. and Edwards, D.R. (1998) High level of gelatinase-B and active gelatinase-A in metastatic glioblastoma. J. Neurooncol. 36, 21–29.

    Article  PubMed  CAS  Google Scholar 

  19. Ueno, H., Nakamura, H., Inoue, M., et al. (1998) Expression and tissue localization of membrane types 1,2 and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res. 57, 2055–2060.

    Google Scholar 

  20. Basbaum, C.B., and Werb, Z. (1996) Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr. Opin. Cell. Biol. 8, 731–738.

    Article  PubMed  CAS  Google Scholar 

  21. Werb, Z. (1997) ECM and cell surface proteolysis: regulating cellular ecology. Cell 91, 439–442.

    Article  PubMed  CAS  Google Scholar 

  22. Brown, L.F., Berse, B., Tognazzi, K., et al. (1992) Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int. 42, 1457–1461.

    Article  PubMed  CAS  Google Scholar 

  23. Brown, L.F., Detmar, M., Tognazzi, K., Abu-Jawdeh, G., and Iruela-Arispe, M.L. (1997) Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor. Lab. Invest. 76, 245–255.

    PubMed  CAS  Google Scholar 

  24. Dvorak, H.F., Brown, L.F., Detmar, M., and Dvorak, A.M. (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146, 1029–1039.

    PubMed  CAS  Google Scholar 

  25. Brown, L.F., Van de Water, L., Harvey, V.S., and Dvorak, H.F. (1998) Fibrinogen influx and accumulation of cross-linked fibrin in healing wounds and tumor stroma. Am.J.Pathol. 130, 455–465.

    Google Scholar 

  26. Murphy, G., and Knauper, V. (1997) Relating matrix metalloproteinase structure to function. Why the “hemopexin” domain? Matrix Biol. 15, 511–518.

    Article  PubMed  CAS  Google Scholar 

  27. Pendas, A.M., Knauper, V., Puente, X.S., Llano, E., Mattei, M.G., Apte, S., Murphy, G., and Lopez-Otin, C. (1997) Identification and characterization of a novel human matrix metalloproteinase witj unique structural characteristic, chromosomal location and tissue distribution. J. Biol. Chem. 272, 4281–4286.

    Article  PubMed  CAS  Google Scholar 

  28. Puente, X.S., Pendas, A.M., Llano, E., Velasco, G., and Lopez-Otin, C. Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res. 56, 944–949.

  29. Atkinson, S.J., Crabbe, T., Cowell, S., et al. (1995) Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J. Biol. Chem. 270, 30679–30685.

    Article  Google Scholar 

  30. Nguyen, M., Arkell, J, and Jackson, C.J. (1999) Thrombin rapidly and efficiently activates gelatinase A in human microvascular endothelial cells via a mechanism indipendent of active MT1 matrix metalloproteinase. Lab.Invest. 79, 467–475.

    PubMed  CAS  Google Scholar 

  31. Herbert, J.M., Lamarche, I., and Carmeliet, P. (1997) Urokinase and tissue-type plasminogen activator are required for the mitogenic and chemotactic effects of bovine fibroblast growth factor and platelet-derived growth factor-BB for vascular smooth muscle cells. J.Biol. Chem. 272, 23585–23591.

    Article  PubMed  CAS  Google Scholar 

  32. Risau, W. (1997) Mechanisms of angiogenesis. Nature 386, 671–674.

    Article  PubMed  CAS  Google Scholar 

  33. Sato, A., Yamamoto, E., and Seiki, M. A. (1994) A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370, 61–65.

    Article  PubMed  CAS  Google Scholar 

  34. Maniotis, A.J., Folberg, R., Hess, A., et al. (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am. J.Pathol. 155, 739–752.

    PubMed  CAS  Google Scholar 

  35. Foldberg, R., Hendrix, M.J., and Maniotis, A.J. (2000) Vasculogenic mimicry and tumor angiogenesis. Am.J. Pathol. 156, 361–381.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Operative Unit of Molecular Biology of Azienda Ospedaliera Careggi, Department of Experimental Pathology and Oncology, University of Firenze, Italy

    Vincenzo Chiarugi

Authors
  1. Vincenzo Chiarugi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marco Ruggiero
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lucia Magnelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chiarugi, V., Ruggiero, M. & Magnelli, L. Angiogenesis and the unique nature of tumor matrix. Mol Biotechnol 21, 85–90 (2002). https://doi.org/10.1385/MB:21:1:085

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/MB:21:1:085

Index Entries

Search

Navigation